Many Patients With Moderate to Severe AD Demonstrate Inadequate Disease Control with Systemic Therapies After 3 to 12 Months of Use
Dermatology Times
DECEMBER 22, 2023
The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.
Let's personalize your content